EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Towards a Cure for HARS Disease

Sarah D P Wilhelm, Rosan Kenana, Yi Qiu iD, Patrick O'Donoghue iD, Ilka U Heinemann

Genes · 2023

DOI: 10.3390/genes14020254 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Sarah D P Wilhelm und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, The University of Western Ontario, London, ON N6A 5C1, Canada. Hauptthemen laut MEDLINE: Histidine, Charcot-Marie-Tooth Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Natural Sciences and Engineering Research Council of Canada, Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histidyl-tRNA synthetase (HARS) ligates histidine to its cognate transfer RNA (tRNAHis). Mutations in HARS cause the human genetic disorders Usher syndrome type 3B (USH3B) and Charcot-Marie-Tooth syndrome type 2W (CMT2W). Treatment for these diseases remains symptomatic, and no disease specific treatments are currently available. Mutations in HARS can lead to destabilization of the enzyme, reduced aminoacylation, and decreased histidine incorporation into the proteome. Other mutations lead to a toxic gain-of-function and mistranslation of non-cognate amino acids in response to histidine codons, which can be rescued by histidine supplementation in vitro. We discuss recent advances in characterizing HARS mutations and potential applications of amino acid and tRNA therapy for future gene and allele specific therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistidineCharcot-Marie-Tooth DiseaseHumansMutationHistidine-tRNA LigaseAminoacylation

Stichwörter der Autor:innen

aminoacyl-tRNA synthetasegenetic diseasemistranslationneurodegeneration

Substanzen

HistidineHistidine-tRNA Ligase

Autor:innen und Institutionen

  • Department of Biochemistry, The University of Western Ontario, London, ON N6A 5C1, Canada.
  • Department of Chemistry, The University of Western Ontario, London, ON N6A 5C1, Canada.

ORCID-Profile: Yi Qiu, Patrick O'Donoghue

Förderung

  • CIHR
  • Natural Sciences and Engineering Research Council of Canada
  • Canada Research Chairs
  • Canadian Institutes of Health Research
  • Ontario Ministry of Research and Innovation
  • Rare Disease Models and Mechanisms network

Zitieren

APA

Wilhelm, S. D. P., Kenana, R., Qiu, Y., O'Donoghue, P., & Heinemann, I. U. (2023). Towards a Cure for HARS Disease. Genes. https://doi.org/10.3390/genes14020254

Vancouver

Wilhelm SDP, Kenana R, Qiu Y, O'Donoghue P, Heinemann IU. Towards a Cure for HARS Disease. Genes. 2023. doi:10.3390/genes14020254

BibTeX
@article{Wilhelm2023,
  author = {Wilhelm, Sarah D P and Kenana, Rosan and Qiu, Yi and O'Donoghue, Patrick and Heinemann, Ilka U},
  title = {Towards a Cure for HARS Disease},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14020254}
}
Kostenlos starten →